EyeArt

Enroll Now

Type of Study:

Adults 18 years or older with Diabetes who do not have persistent visual impairment

Title of Study:

Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

Short Title:

EN-01

Study Length: 1 visit

Target Age/Sex: 18 or older, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov